|
interprofessional education |
28 |
|
partnership model |
28 |
|
social interaction anxiety |
28 |
|
sjogren's syndrome |
15 |
|
dendrobium officinale |
13 |
|
polysaccharides |
13 |
|
apoptosis |
12 |
|
covid-19 |
11 |
|
antigen-presentation |
10 |
|
aquaporin 5 |
10 |
|
cytokine and chemokine response |
10 |
|
mers-cov |
10 |
|
pathogenesis |
10 |
|
sars-cov |
10 |
|
sjögren's syndrome |
10 |
|
viral replication |
10 |
|
autoantibodies |
9 |
|
b-cell suppression |
8 |
|
mitochondrial dysfunction |
8 |
|
mouse model |
8 |
|
sars-cov-2 |
8 |
|
aqp5 |
7 |
|
breg cells |
7 |
|
il-10 |
7 |
|
t follicular helper cells |
7 |
|
autoimmune diseases |
6 |
|
a-253 |
5 |
|
animals |
5 |
|
apoptosis - drug effects |
5 |
|
chinese herbal medicine |
5 |
|
colorectal cancer |
5 |
|
confirmatory factor analysis |
5 |
|
cytokines |
5 |
|
diet therapy |
5 |
|
functional food |
5 |
|
m3 mucarinic acetylcholine receptor |
5 |
|
online interprofessional education |
5 |
|
t cells |
5 |
|
t follicular helper |
5 |
|
tnf-α |
5 |
|
validation |
5 |
|
acteoside |
4 |
|
amyloid beta-peptides - toxicity |
4 |
|
aquaporin 5 - metabolism |
4 |
|
b cells |
4 |
|
bcl-2-associated x protein - biosynthesis |
4 |
|
bcl-2-associated x protein - metabolism |
4 |
|
beta-amyloid |
4 |
|
caspase 3 - metabolism |
4 |
|
cell line |
4 |
|
cyclooctanes - pharmacology |
4 |
|
cytokine |
4 |
|
cytokines - biosynthesis |
4 |
|
dendrobium - chemistry |
4 |
|
diabetes |
4 |
|
dibenzocyclooctadiene lignans |
4 |
|
dioxoles |
4 |
|
disease models, animal |
4 |
|
experimental sjögren’s syndrome |
4 |
|
female |
4 |
|
homocysteine |
4 |
|
homocysteine - toxicity |
4 |
|
humans |
4 |
|
inflammation - drug therapy - metabolism |
4 |
|
lignans - pharmacology |
4 |
|
lupus nephritis |
4 |
|
lymphocytes - drug effects |
4 |
|
m3 muscarinic receptor |
4 |
|
mechanism |
4 |
|
medicinal plants |
4 |
|
mice |
4 |
|
mice, inbred c57bl |
4 |
|
neuroprotective agents - pharmacology |
4 |
|
orchidaceae |
4 |
|
pc12 cells |
4 |
|
peptide fragments - toxicity |
4 |
|
phytochemical |
4 |
|
polycyclic compounds |
4 |
|
polysaccharide |
4 |
|
polysaccharides - therapeutic use |
4 |
|
primary sjögren’s syndrome |
4 |
|
proto-oncogene proteins c-bcl-2 - biosynthesis |
4 |
|
rats |
4 |
|
reactive oxygen species - metabolism |
4 |
|
saliva - secretion |
4 |
|
schisandra - chemistry |
4 |
|
schisandra chinensis (turcz.) baill. |
4 |
|
schisandrin b |
4 |
|
schisandrin c |
4 |
|
sjogren's syndrome - therapy |
4 |
|
submandibular gland - drug effects |
4 |
|
systemic lupus erythematosus |
4 |
|
t follicular regulatory cells |
4 |
|
tlr |
4 |
|
traditional chinese medicine |
4 |
|
treatment outcome |
4 |
|
ace2 |
3 |
|
adoptive transfer |
3 |
|
aging |
3 |
|
alisol b 23-acetate |
3 |
|
anti-coronavirus |
3 |
|
anti-immunoinflammatory activity |
3 |
|
antibody production |
3 |
|
arkadia |
3 |
|
autoimmune disease |
3 |
|
autoimmune disorders |
3 |
|
b lympho |
3 |
|
batf |
3 |
|
calycosin |
3 |
|
caveolin-1 |
3 |
|
cia |
3 |
|
cp: immunology |
3 |
|
cytecytokine production |
3 |
|
fenofibrate |
3 |
|
fibrosis |
3 |
|
humanized |
3 |
|
icos |
3 |
|
immunization |
3 |
|
in situ detection |
3 |
|
inflammation |
3 |
|
interleukin-17 |
3 |
|
latent tgf-β1 |
3 |
|
marginal zone b |
3 |
|
mekk3 |
3 |
|
metabolism |
3 |
|
methotrexate |
3 |
|
migration |
3 |
|
neutralization |
3 |
|
olfactory ecto-mesenchymal stem cells |
3 |
|
ppar |
3 |
|
proteasome inhibition |
3 |
|
regulatory b cells |
3 |
|
sjogren |
3 |
|
sjögren disease |
3 |
|
sjögren syndrome |
3 |
|
sjögren's disease |
3 |
|
sjögren’s disease |
3 |
|
sjögren’s syndrome |
3 |
|
smad7 |
3 |
|
sting |
3 |
|
th17 cells |
3 |
|
tile scan |
3 |
|
treg cell |
3 |
|
type i ifn |
3 |
|
autoimmunity |
2 |
|
b cell tolerance |
2 |
|
bladder cancer |
2 |
|
chinese medicine |
2 |
|
dendrobium - therapeutic use. |
2 |
|
effector t cell |
2 |
|
elisa |
2 |
|
elispot |
2 |
|
experimental autoimmune encephalomyelitis |
2 |
|
flow cytometry |
2 |
|
il-2r |
2 |
|
immunofluorescence |
2 |
|
inflammatory cytokines |
2 |
|
microenvironment |
2 |
|
multiple sclerosis |
2 |
|
mutations |
2 |
|
network pharmacology |
2 |
|
nf-κb |
2 |
|
nitration |
2 |
|
pcr |
2 |
|
peroxynitrite |
2 |
|
sjögren's syndrome. |
2 |
|
uc |
2 |
|
urothelial carcinoma |
2 |
|
b lymphocyte subsets |
1 |
|
biologics |
1 |
|
efficacy |
1 |
|
interleukin-2 (il-2) |
1 |
|
lymphoma risk |
1 |
|
meta-analysis |
1 |
|
nano |
1 |
|
nanocarriers |
1 |
|
ocular drug delivery |
1 |
|
oral and maxillofacial surgery |
1 |
|
p-stat3 |
1 |
|
pathology |
1 |
|
polysaccharide-based nanomaterials |
1 |
|
regulatory t cell (treg) |
1 |
|
safety |
1 |
|
salivary gland function |
1 |
|
sjogren's disease |
1 |
|
stratification analysis |
1 |
|
systemic lupus erythematosus (sle) |
1 |
|
tfh cells |
1 |
|
tofacitinib |
1 |
